High prevalence of fatty liver and its association with metabolic syndrome among rural adults with chronic hepatitis C: Implications for primary healthcare

Table 2 The association between moderate to severe fatty liver, liver function and components of metabolic syndrome

Outcome	Regression coefficient (95% CI)^a	P value
Liver function^b
GOT, U/L	5.54 (-0.19 to 11.27)	0.058
GPT, U/L	3.63 (-2.93 to 10.19)	0.277
GGT, U/L	7.92 (0.48 to 15.36)	0.037
Components of MetS^c
Waist circumference, cm	4.93 (2.85 to 7.02)	< 0.001
Systolic blood pressure, mmHg	3.72 (-0.49 to 7.94)	0.084
Diastolic blood pressure, mmHg	3.26 (0.48 to 6.03)	0.021
Fasting blood glucose, mg/dL	3.51 (-2.46 to 9.48)	0.249
Triglyceride, mg/dL	12.41 (0.39 to 24.42)	0.043
High-density lipoprotein, mg/dL	-4.14 (-7.40 to -0.87)	0.013
Number of components of MetS	0.70 (0.41 to 0.99)	< 0.001

Abbreviation: CI Confidence interval, GOT Glutamic-oxalocetic transaminase, GPT Glutamic-pyruvic transaminase, GGT Gamma-glutamyl transferase. MetS Metabolic syndrome
^aAdjusted for age, sex and education level
^bQuantile regression
^cLinear regression

ISSN: 1471-2458